The EU-funded HORIZON project siNPAIN held its 6th progress meeting in Porto last week. Project partners came together to review key milestones, exchange updates, and align the next steps of this innovative initiative.
Asphalion is the regulatory partner of the project and leader of Work Package 6, guiding it through the appropriate regulatory pathway. At the meeting, our experts Núria Coderch and Joan Cabellos updated the group on the achievements and ongoing tasks.
The siNPAIN project aims to develop an innovative therapy that combines RNA technology, nanocarriers, and an enhanced hyaluronic acid-based intra-articular knee viscosupplement (IA-HA) and is currently on its 37th month of the total 54-month project duration.
For more information about the siNPAIN project, visit the website: https://www.osteoarthritis-sinpain.eu/
For additional information and for all your EU-funded projects, you can also contact us at: [email protected]
